Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
128,8 USD | +1,08 % | +11,37 % | +33,54 % |
Resumen de negocios
Número de empleados: 1 314
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
RNA-targeted Therapeutics, Gene Therapy and Other Genetic Therapeutic Modalities
100,0
%
| 933 | 100,0 % | 1 243 | 100,0 % | +33,26 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 933 | 100,0 % | 1 243 | 100,0 % | +33,26 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Douglas Ingram
CEO | Chief Executive Officer | 61 | 26/06/17 |
Ian Estepan
DFI | Director of Finance/CFO | 48 | 01/01/15 |
Bilal Arif
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 48 | 01/06/18 | |
Will Tilton
HRO | Human Resources Officer | - | - |
Alison Nasisi
HRO | Human Resources Officer | - | - |
Dallan Murray
PRN | Corporate Officer/Principal | - | 01/01/13 |
Diane Berry
PRN | Corporate Officer/Principal | - | 01/12/11 |
Ryan Brown
LAW | General Counsel | 46 | 01/01/18 |
Joseph Bratica
AUD | Comptroller/Controller/Auditor | 60 | 01/03/17 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Douglas Ingram
CEO | Chief Executive Officer | 61 | 26/06/17 |
M. Wilsey
CHM | Chairman | 71 | 31/03/09 |
Richard Barry
BRD | Director/Board Member | 65 | 02/06/15 |
Director/Board Member | 86 | 01/06/10 | |
Stephen Mayo
BRD | Director/Board Member | 62 | 16/11/21 |
Claude Nicaise
BRD | Director/Board Member | 71 | 02/06/15 |
Michael Chambers
BRD | Director/Board Member | - | 02/06/22 |
Kathryn Boor
BRD | Director/Board Member | 65 | 02/06/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 94 505 608 | 89 898 718 ( 95,13 %) | 0 | 95,13 % |
Información de la empresa
Sarepta Therapeutics, Inc.
215 First Street Suite 415
02142, Cambridge
+617 274 4000
http://www.sareptatherapeutics.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+33,54 % | 12,17 mil M | |
-2,31 % | 103 mil M | |
+0,56 % | 95,28 mil M | |
+1,69 % | 22,15 mil M | |
-17,37 % | 21,02 mil M | |
-9,30 % | 18,15 mil M | |
-41,01 % | 16,74 mil M | |
-14,85 % | 16,05 mil M | |
+3,21 % | 13,68 mil M | |
-24,71 % | 8240,57 M |
- Bolsa de valores
- Acciones
- Acción SRPT
- Empresa Sarepta Therapeutics, Inc.